Spirometry Market Research Report Information By Product (Tabletop Spirometry, Hand-held Spirometry, and Desktop Spirometry), By Technology (PFM, Volume Measurement Spirometry, and Flow Measurement Spirometry), By Application (Diagnostic and Treatment Monitoring), By End Users (Hospitals & Clinics, Home Care, Diagnostic Centers, and Research & Academic Institutes), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030

Global Spirometry Market Overview

Spirometry Market Size was valued at USD 0.5 billion in 2022 and is projected to grow from USD 0.6 Billion in 2023 to USD 1.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.9% during the forecast period (2023 - 2030). 

The market is anticipated to be driven by an increase in the prevalence of chronic respiratory disorders, rising demand for home healthcare, and technological advances.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Cervical Fusion Market Trends

• 
  

  Growing diagnostic tool technological progress and increasing COPD prevalence to boost the market growth

  
  

To assess the fundamental operation of the lungs, lung function tests are important. Physicians can diagnose various lung illnesses, including COPD, by evaluating PFTs, which measure lung volumes, lung capacities, rates of flow, and gas exchange. On the market, technological advancements are anticipated to have a significant impact. Early diagnosis of COPD is anticipated to be made possible by significant expenditures made by the major market participants in the substantial research and development of novel and cutting-edge diagnostic and monitoring technologies.

The underutilization of pulmonary function testing has been addressed by creating portable, hand-held, and user-friendly spirometry devices. For instance, the U.S. FDA approved NuvoAir's linked spirometer for nationwide sales in January 2020. The system treats conditions like cystic fibrosis, asthma, and COPD. Thus, one of the market-driving growth elements is ongoing innovation.

The third biggest cause of death globally, COPD places a heavy burden on patients and healthcare systems. According to the National Heart, Lung, and Blood Institute, COPD, which affects about 16 million Americans, is the main cause of death in the country. Smoking is a significant risk factor for COPD. Yet, other environmental exposures like exposure to biomass fuels and air pollution may also harm your health.

Spirometry Market Segment Insights

Spirometry Product Insights

Based on product, the global spirometry market segmentation includes tabletop spirometry, hand-held spirometry, and desktop spirometry. The tabletop category dominated the global spirometry market with a 43.6% revenue share in 2022. Due to its widespread use in treating respiratory illnesses like asthma and COPD, and other pulmonary diseases, the market is anticipated to expand quickly. Due to their portability and ability to save hundreds of diagnostic test findings and print them on a normal printer, portable spirometers have grown in popularity. Moreover, outcomes can be uploaded to patients' electronic medical records and flash drives (EMRs). By expanding pulmonary function testing outside of the laboratory and into primary care settings, hand-held portable spirometers have made it possible to identify lung blockages early and start therapy.

On the other hand, desktop spirometers are anticipated to expand at the quickest rate throughout the projection period, with a compound annual growth rate (CAGR) of 10.53%. This is because they offer integrated clinical information for better clinical judgments. They could lighten the load of paperwork. Also, practitioners can assess pulmonary congestion or restriction thanks to instant access to patient records via the computer.

Spirometry Technology Insights

Based on technology, the global spirometry market segmentation includes PFM, volume measurement spirometry, and flow measurement spirometry. In 2022, the flow measurement category held the largest market share, with 66.7% of the total. This is because it has numerous uses in pulmonary function tests. They are simpler to handle because they typically use tabletop technology and don't have any moving parts. Spirometers for flow measurement are very simple to automate due to their comparative superior frequency characteristics. They also offer a graphic examination of the flow produced by the technique. Flow spirometers monitor both inspiration and expiration. These gadgets are preferred in workplace and healthcare environments.

The market segment for peak flow measurement is anticipated to develop at the fastest rate during the projected period. Peak flow measurement tools can alert users before an asthma attack by displaying signs of bronchial airway contraction. As a result, asthma patients can receive medical attention when they need it. Peak flow and FEV1 measurements can be recorded at home using mobile applications like Smart One, and the findings can be electronically transmitted to the doctor.

Spirometry Application Insights

The global spirometry market data has been bifurcated by application into diagnostic and treatment monitoring. In 2022, the diagnostic segment had the largest segment share. The high and increasing prevalence of COPD worldwide and the simplicity of spirometry-based COPD diagnosis are two factors that contribute to the substantial proportion of this market. Contrarily, the segment for treatment monitoring is anticipated to develop at the quickest rate throughout the projection period. This results from the increased prevalence of asthma in adults and children. Over 14% of children worldwide have asthma, and the yearly expenditures for treating asthma in the U.S. are nearly USD 18 billion.

Figure 2: Spirometry Market, by Application, 2022 & 2030 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Spirometry End User Insights

Based on End Users, the global spirometry industry has been segmented into hospitals & clinics, home care, diagnostic centers, and research & academic institutes. Throughout the forecast period, the hospitals & clinics segment is anticipated to hold a significant market share. The dominance resulted from rising healthcare costs that encouraged using sophisticated pulmonary function testing equipment. For instance, Ruby Hall in Pune, India, declared the installation of the pulmonary function test device in August 2019. According to the hospital, the device aids in producing an accurate test for lung disease.

Because more patients are choosing to have their lung function tests at the nearest diagnostic center, the diagnostic centers are anticipated to experience the fastest CAGR growth. Due to the centers' increased use of mobile devices, sales have increased.

Spirometry Regional Insights

By Region, the study provides market insights into North America, Europe, Asia-Pacific and Rest of the World. The fact that North America held the largest market share in 2022 (41.8%) was mostly caused by the rising incidence of respiratory disorders. Spirometers, which aid in disease control and are frequently used by doctors in hospitals, have become more popular due to the rise in occurrences of asthma and COPD. The United States has also been noted as an early adopter of technologies that helps lower COPD rates. Due to those above, the market is anticipated to expand throughout the forecast period.

Further, the major countries studied in the market report are The U.S., Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: SPIROMETRY MARKET SHARE BY REGION 2022 (%)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe's spirometry market accounts for the second-largest market share due to the availability of cutting-edge treatment facilities, government backing for the growth of the healthcare industry, an aging population, and an increase in the incidence of COPD and asthma disorders. Further, the German spirometry market held the largest market share, and the U.K. spirometry market was the fastest-growing market in the European Region.

The Asia-Pacific Spirometry Market is expected to grow at the fastest CAGR from 2023 to 2030. The Asia Pacific market is anticipated to be driven by improvements in primary care activities for the early detection and management of chronic lung illnesses, including COPD and asthma, over the forecasted period. Moreover, China's spirometry market held the largest market share, and the Indian spirometry market was the fastest-growing market in the Asia-Pacific region.

Cervical Fusion Key Market Players & Competitive Insights

Leading industry players are investing a lot of money in R&D to expand their product offerings, which will spur further market growth for spirometry. With significant industry changes like new product releases, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations, market participants are also undertaking various strategic activities to expand their global presence. Spirometry sector competitors must provide affordable products to grow and survive in a more cutthroat and competitive market climate.

Manufacturing locally to cut operating costs is one of the main business tactics manufacturers use in the global spirometry industry to benefit customers and develop the market sector. The spirometry market major player such as NDD Medical Technologies Inc. (U.S.), CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), and others are working on expanding the market demand by investing in research and development activities.

Schiller AG (Switzerland) is a top producer and supplier of software solutions for the medical sector and devices for cardiopulmonary diagnostics, defibrillation, and patient monitoring. Schiller has dedicated more than 40 years to the struggle against sudden cardiac death. In 2018, Schiller AG opened a new manufacturing site in Guangzhou, China.

Also, Tactio Health Group (Canada) is a world leader in mobile health systems, with millions using its mobile health applications on iOS and Android, enjoying the personal and family benefits of being led to live a more active, healthier lifestyle. In 2017, MIR partnered with Tactio Health Group to develop telemedicine solutions for COPD.

Key Companies in the spirometry market include

• NDD Medical Technologies Inc. (U.S.)


• Carefusion Corporation (U.S.)


• MGC Diagnostics Corporation (U.S.)


• Hill-Rom Holdings Inc. (U.S.)


• Nihon Kohden Corporation (Germany)


• Midmark Corporation (U.S.)


• Schiller AG (Switzerland)-


• Koninklijke Philips N.V. (The Netherlands)


• Smiths Medical Inc. (U.S.)


• MGC Diagnostics Corporation (U.S.), among others

Spirometry Industry Developments

September 2022: To connect the ZEPHYRx cloud spirometry platform with RxCap's remote monitoring platform, RxCap, Inc. forged a relationship with ZEPHYRx. RxCap's enterprise clients, including payers and providers, can now track the lung function of their patients and members who suffer from serious pulmonary disorders.

August 2022: IoT-enabled hand-held spirometers are now available in hospitals across the nation thanks to a collaboration between AstraZeneca and respiratory healthcare platform Alveofit. This hand-held spirometer's Internet of Things (IoT) connectivity enables remote patient monitoring and tele-spirometry with comprehensive care management tools.

January 2020: Through a collaboration with Roche Italy, NuvoAir will make its digital respiratory technology available in cystic fibrosis clinics nationwide.

Spirometry Market Segmentation

Spirometry Product Outlook

• Tabletop Spirometry


• Hand-held Spirometry


• Desktop Spirometry

Spirometry Technology Outlook

• PFM


• Volume Measurement Spirometry


• Flow Measurement Spirometry

Spirometry Application Outlook

• Diagnostic


• Treatment Monitoring

Spirometry End User Outlook

• Hospitals & Clinics


• Home Care


• Diagnostic Centers


• Research & Academic Institutes

Cervical Fusion Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America